Intra-individual variability in lopinavir plasma trough concentrations supports therapeutic drug monitoring

被引:25
作者
Boffito, M [1 ]
Back, DJ
Hoggard, PG
Caci, A
Bonora, S
Raiteri, R
Sinicco, A
Reynolds, HE
Khoo, S
Di Perri, G
机构
[1] Univ Liverpool, Dept Pharmacol, Liverpool L69 3BX, Merseyside, England
[2] Univ Turin, Dept Infect Dis, Turin, Italy
关键词
D O I
10.1097/00002030-200305020-00029
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:1107 / 1108
页数:2
相关论文
共 7 条
  • [1] Therapeutic drug monitoring in HIV infection: current status and future directions
    Back, D
    Gatti, G
    Fletcher, C
    Garaffo, R
    Haubrich, R
    Hoetelmans, R
    Kurowski, M
    Luber, A
    Merry, C
    Perno, CF
    [J]. AIDS, 2002, 16 : S5 - S37
  • [2] HUITEMA ADR, 2001, 2 INT WORKSH CLIN PH
  • [3] Lopinavir
    Hurst, M
    Faulds, D
    [J]. DRUGS, 2000, 60 (06) : 1371 - 1379
  • [4] LUBER AD, 2000, 5 INT C DRUG THER HI
  • [5] Nelfinavir plasma levels under twice-daily and three-times-daily regimens: High interpatient and low intrapatient variability
    Marzolini, C
    Buclin, T
    Decosterd, LA
    Biollaz, J
    Telenti, A
    [J]. THERAPEUTIC DRUG MONITORING, 2001, 23 (04) : 394 - 398
  • [6] REYNOLDS HE, 2001, BR J CLIN PHARM, V52, pP481
  • [7] Plasma population pharmacokinetics and penetration into cerebrospinal fluid of indinavir in combination with zidovudine and lamivudine in HIV-1-infected patients
    Zhou, XJ
    Havlir, DV
    Richman, DD
    Acosta, EP
    Hirsch, M
    Collier, AC
    Tebas, P
    Sommadossi, JP
    [J]. AIDS, 2000, 14 (18) : 2869 - 2876